Chinese Medical Information Portal Website (Taiwan Medical Network-TMN) - OldDoc Wu's Series
(Established in March 1996)
References for Dr. Wu's liver diseases
Dr. Wu's Liver diseases
for professionals (medical students and residents)

(by Jau-Shin WU, M.D., Ph.D.)
(Posted Sep. 16, 1996; Updated May 14, 2009)



  1. Acharya SK, Dasarathy S, Kumer TL, et al: Fulminant hepatitis in a tropical population:clinical course, cause, and early predictors of outcome. Hepatology 1996; 23: 1448-55.
  2. Acharya SK, Panda SK, Saxena A, Gupta SD.: Acute hepatic failure in India: a perspective from the East. J Gastroenterol Hepatol 2000 May;15(5):473-9.
  3. Beneduce F, Beneduce F, Pisani G, Divizia M, Pana A, Morace G. Complete nucleotide sequence of a cytopathic hepatitis A virus strain isolated in Italy. Virus Res 1995 May;36(2-3):299-309.
  4. Bendinelli M, Pistello M, Maggi F, et al. Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans. Clin Microbiol Rev 2001; 14: 98-113.
  5. Bermuau J, Bermunau JP. Classifying acute liver failure. Lancet; 1993;342: 252-3. (Commentary)
  6. Bernuau J, Goudeau A, Poynard t, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986; 6: 648-51.
  7. Bernuau J, Rueff B. BenhamouJP. Fulminant and subfulminant liver failure: definitions and causes. Sem Liv Dis 1986; 6: 97-106
  8. Bernuau J, Samuel D, Durand F, et al. Criteria for emergency liver transplantaion in patients with acute viral hepatitis and factor V (FV) below 50% of normal: a prospective study. Hepatology 1991; 14: 49A (abstr).
  9. CDC: Hepatitis A Vaccination of Men Who Have Sex With Men -- Atlanta, Georgia, 1996-1997; MMWR; 1998; Vol 47, No 34;708)
  10. Chan YJ, Hsu YH, Chen MC, et al. TT virus infection among hemodialysis patients at a medical center in Taiwan. J Microbiol Immunol Infect 2000; 33: 14-8.
  11. Chang MH, Chen CJ, Lai MS, et al. Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in Children. NEJM, 1997; 336:1855.
  12. Chen HL, Chang, MH, Ni YH, et al. Seroepidemiology of Hepatitis B Virus Infection in Children - Ten Years of Mass Vaccination in Taiwan. JAMA; 1996; 276: 906-908.
  13. Chien RN, Yeh CT, Tsai SL, et al. Determinants for sustained HBeAg response to lamivudine therapy. Hepatology 2003; 38: 1267-73.
  14. Desai SM, et al. Prevalence of TT Virus Infection in US Blood Donors and Populations at Risk for Acquiring Parenterally Transmitted Viruses. J Infect Dis 1999;179: 1242-1244
  15. Dhenain M, Bouletreau A, Bourguignon F, et al. The TT virus: review of the literature. Clin Invest Med 2000; 23: 307-17(in french, English summary).
  16. Emmet B. Keeffe, Iwarson S, et al. Safety and immunogenecity of hepatitis A vaccine in patient with chronic live disease. Hepatology, 1998; 27: 881.
  17. Favorov MO, Kosoy MY, Tsarev SA, Childs JE, Margolis HS. Prevalence of antibody to hepatitis E virus among rodents in the United States. J Infect Dis 2000 Feb;181(2):449-55.
  18. Fukuda R, Ishimura N, Kushiyama Y, et al. Hepatitis B virus X gene mutation asociated with the majority of serologically "silent" non-b, non-c chronic hepatitis. Microbiol Immunol, 1996; 40: 481-8.
  19. Fung SK, Lok ASF. Hepatitis B genotypes: Do they play a role in the outcome of HBV infection? (Editorial). Hepatology 2004; 40: 790-792.
  20. Hamada H, Yatsuhashi H, Yano K et al.,Impact of aging on the development of hepatocellular carcinoma in patient with posttransfusio chronic hepatitis. Cancer 2002; 95: 331-339.
  21. Hsieh SY, Meng XJ, Wu YH, Liu ST, Tam AW, Lin DY, Liaw YF.: Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus. J Clin Microbiol 1999 Dec;37(12):3828-34.
  22. Huang YH, Wu JC, Chiang TY, et al. Detection and viral nucleotide sequence analysis of transfusion-transmitted virus infection in acute fulminant and non-fulminant hepatitis. J Viral Hepat 2000 7: 56-63.
  23. Ishida T. et al: Outbreak of Hepatitis A Virus Infection among HIV-1 Seropositive Men Who Had Sex with Men; Jpn.J.Infect.Dis. 1999; 52: 131-132.
  24. Kao JH, Chen DS. HBV genotypes and ouucome of HBV infection (Correspondence). Hepatology 2005; 41:216-217.
  25. Kao JH, Chen DS, :Global control of Hepatitis B virus infection. Lancet Infect Dis 2002; 2: 395-403.
  26. Kao JH, Chen PJ, Lai MY, ert al: Hepatitis B genotypes and spontaneous hepatitisB e antigen seroconversion in Taiwanese hepatitis B carriers. J Med Virol 2004; 72: 363-369.
  27. Kiyohara T, Satoh T, Yamamoto H, et al: The latest seroepidemiological patterns of hepatitis A in Japan. Jpn J Med Sci Biol 1997; 50:123-131.
  28. Li TC, Zhang J, Shinzawa H, Ishibashi M, Sata M, Mast EE, Kim K, Miyamura T, Takeda N.: Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus. J Med Virol 2000 Nov;62(3):327-33.
  29. Liaw YF: Hepatitis flares and hepattis B e antigen seroconversion: Implication in ant-hepatitis B virus therapy. J of Gastroenterology and Hepatology. 2003; 18: 246-256.
  30. Liaw YF, Leung N, Guan R, Lau GK and Merican I: Asian-Pacific consensus statement on the management of chronic hepatitis B: An update. J of Gastroenterology and Hepatology. 2003; 18: 239-245.
  31. Lin H-H, Wu J-S, Lu C-F, Wong C-K: Hepatitis B virus infection among aboriginal children in eastern Taiwan. J Formosan Med Assoc 1992; 91: 691-693. (English)
  32. Lucke B, Mallory T. Fulminant form epidmic hepatitis. Am J Pathl 1946; 22: 867-945.
  33. Mast EE, Alter MJ, Holland PV, and Purcell RH. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 1998;27(3):857-61.
  34. Mulhall BP, Ong JP, Younossi ZM. Non-alcoholic fatty liver disease: An overview. J Gastroenterol Hepatol 2002 Nov;17(11):1136-43
  35. Naoumov N, et al. Presence of a newly described human DNA viru (TTV) in patients with liver disease. Lancet, 1998; 352: 195-87.
  36. Nishizawa T, Okamoto H, Konishi K, et al. A novel virus (TTV) associated with elevated transaminase level in posttransfusion hepatitis of unknown etiology. Biomchemical and biophysical reseaarch communications, 1997; 241: 92-97.
  37. Okamoto H, et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatology Res, 1998; 10: 1-16.
  38. Okamoto H, et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatology Res, 1998; 10: 1-16.
  39. O'Grady JG, Schalm SW, Williams R,. Acute liver failure: redefining the syndrome. Lancet; 1993; 342: 273-5.
  40. Tam K-M, Wu J-S: Ultasonographic diagnosis of fatty liver. J Formosan Med Assoc 1984; 85: 45-53. (Chinese)
  41. Tam K-M, Wu J-S: Diagnostic usefulness of serum total bile acid level in liver disease. J Formosan Med Assoc 1989; 87: 944-947. (English)
  42. Tanaka E, Takeda N, Tian-Chen L, Orii K, Ichijo T, Matsumoto A, Yoshizawa K, Iijima T, Takayama T, Miyamura T, Kiyosawa K. : Seroepidemiological study of hepatitis E virus infection in Japan using a newly developed antibody assay. J Gastroenterol 2001 May;36(5):317-21.
  43. Trey C, Davidson LS: The management of fulminant hepatic failure. In: Popper H, Shaffner F, eds. Progress in liver disease. New York: Grune and Stratton, 1970: 282-98.
  44. Uchida T, Kaneita Y, Gotoh K, et al. Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection. J. Med. Virol, 1997; 52: 399-405.
  45. Uchida T, Saitoh T, Shinzawa H. Mutations of the X region of hepatitis B virus and their clinical implications. Pathol Int. 1997; 47:183-193.
  46. Vento S, Garofano T, Renzini C, et al: Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C. N Engl J Med 338: 286-290.[Full text}
  47. Wu JC, Chen CM, Chiang TY, Sheen IJ, Chen JY, Tsai WH, Huang YH, Lee SD.: Clinical and epidemiological implications of swine hepatitis E virus infection. J Med Virol 2000 Feb;60(2):166-71
  48. Wu JC, Chen CM, Chiang TY, Tsai WH, Jeng WJ, Sheen IJ, Lin CC, Meng XJ. Spread of hepatitis E virus among different-aged pigs: two-year survey in Taiwan. J Med Virol 2002 Apr;66(4):488-92
  49. Wu J-S, Chen C-H et al.: Hepatitis A virus infection in Taiwan. J Formosan Med Assoc 1980; 79: 694-699. (English)
  50. Wu J-S, Chen C-H et al.: Hepatitis B virus infection in Taiwan-- with reference to anti-HBc vs HBsAg and anti-HBs. J Formosan Med Assoc 1980; 79: 760-767. (English)
  51. Wu J-S: Differential diagnosis of type B chronic active hepatitis from type B acute hepatitis by clinical features. J Formosan Med Assoc 1983; 82: 923-927. (Chinese)
  52. Wu J-S, Tam K-M: Hepatitis delta virus infection among chronic hepatitis B surface antigen carrier patients of a general hospital in northern Taiwan. J Formosan Med Assoc 1987; 86: 864-868. (English)
  53. Wu J-S, Ko Y-C, Liu W-T: Hepatitis B type 2. Lancet 1988; 1: 990. (letter) (English)
  54. Wu J-S, Tam K-M: Immune response to hepatitis B vaccine in subjects positive for serum hepatitis B core antibody alone. J Formosan Med Assoc 1988; 87: 944-947. (English)
  55. Wu J-S, Ko Y-C, Liu W-T: HBV-2 infection in Taiwan. In Proceedings of the Second International Symposium on Viral Hepatitis and Hepatocellular Carcinoma. Dec. 7-9, 1988, Taipei. Hong-Kong, Encerpta Medica, Current Clinical Practice Series 57, 1990: 226-230. (English)
  56. Wu J-S, Lu C-F, Liu W-T, Lin S-Y: Prevalence of antibodies to hepatitis C virus (anti-HCV) in different population in Taiwan. Chinese J Microbiol and Immunol 1991; 24: 55-60. (English)
  57. Wu J-S, Lu C-F, Chou W-H, Lee H-F, Wu Y-C, Lin S-Y: High prevalence of hepatitis C virus infection in aborigines in Taiwan. Jpn J Med Sci Biol 1992; 44: 165-174. (English)
  58. Wang JT, Lee CZ, Kao JH, et al. Incidence and clinical presentation of posttransfusion TT virus infection in prospectively followed transfusion recipients: emphasis on its relevance to hepatitis. Transfusion 2000; 40: 596-601.
  59. Wu J-S, Nil S-L, Chou W-H, Sheu L, Liu W-T, Chen C-Y, Tang B-H, Lu C-F: Implications of isolated HBsAg positivity--hepatitis B virus variant and immune incompetence. J Gastroenterol Hepatol 1993; 8: S123-127(English)
  60. Wu J-S, Lu C-F, Wu L-Z, Wong C-K, Wu Y-C, Lee T-C, Chen K-L, Chen H-Y: Changing seroepidemiology of hepatitis A virus infection between two regions differing in socioeconomic status in Taiwan. J Forms Med Assoc 1993; 92: 812-815. (English)
  61. Wu J-S, Lee H-F, Hsiau H-L, Lu H-Y, Chou W-H, Lu C-F, Chen H-Y, Lee F-N, Chen P-Y, Tam K-M: Genotype distribution of hepatitis c virus (HCV) infection in Taiwan. J Med Virol 1994; 44:74-79.(English)
  62. .

[Dr. Wu's Health Note- Home] [Taiwan Medical Network]
[Web sites for medical students][Curriculum Vitae ]

(By Jau-Shin Wu, M.D.; Posted Sep. 16, 1996; Revised May 12, 2009)

(TMN) Since June 09, 2002

(Dr. Wu's Liver D) Since Jan. 01, 2008

(Olddoc)Since Jan. 01, 2008

(TMN) Since Jan. 01, 2008